Gastrointestinal Cancer News

SAN FRANCISCO — Daniel Chang, MD, associate professor of radiation oncology at Stanford University, discusses randomized controlled trial data presented at the Gastrointestinal Cancers Symposium, which found that a short-course 5-day radiation regimen followed by consolidated chemotherapy prior to surgery appeared as effective as and less toxic than the standard 5-week chemoradiation course for patients with advanced rectal cancer.

Approximately 15% of patients diagnosed with colorectal cancer received their diagnosis at an age younger than 50 years, according to the results of a SEER analysis.

The National Comprehensive Cancer Network awarded research grants to eight investigators.

SAN FRANCISCO — Kenneth Wang, MD, from the Mayo Clinic in Rochester, Minn., discusses his talk given as part of a debate on whether or not to screen for Barrett’s esophagus, which he delivered at the Gastrointestinal Cancers Symposium.

SAN FRANCISCO — Douglas K. Rex, MD, MACP, MACG, FASGE, AGAF, from Indiana University School of Medicine, discusses his presentation on novel endoscopic approaches in colorectal cancer screening, which he delivered at the Gastrointestinal Cancers Symposium.

SAN FRANCISCO — Among patients with resected pancreatic cancer, overall survival was significantly better when adjuvant therapy was performed at a high-volume center rather than by a community oncologist, according to data presented at the Gastrointestinal Cancers Symposium.

Sally Vernon, PhD, chair of the department of health promotion and behavioral sciences at The University of Texas Health Science Center at Houston School of Public Health, has been appointed to the board of scientific counselors for clinical sciences and epidemiology at the NCI.

SAN FRANCISCO — Nivolumab monotherapy was well tolerated and showed antitumor activity in patients with advanced and metastatic gastric or gastroesophageal junction cancers who received heavy pretreatment, according to initial results from the CheckMate-032 trial presented at the Gastrointestinal Cancers Symposium.

SAN FRANCISCO — Keith T. Wilson, MD, from Vanderbilt University Medical Center, discusses his keynote lecture on Helicobacter pylori-induced gastric carcinogenesis, which he delivered at the Gastrointestinal Cancers Symposium.

SAN FRANCISCO — After induction therapy, patients with resectable esophageal adenocarcinoma achieved superior pathological complete response with pre-operative carboplatin/paclitaxel based chemoradiation compared with oxaliplatin/capecitabine based chemoradiation, according to phase 2 study results presented at the Gastrointestinal Cancers Symposium.